Background New drugs and new evidence concerning the use of established treatments
have become available since the publication of the first European League Against …

Gout, a disease recognized since antiquity, has increased in prevalence in recent years and
the clinical profile of this disease has become increasingly complex, owing to large numbers …

Objective To estimate the prevalence of gout and hyperuricemia based on the latest
nationally representative sample of US men and women (National Health and Nutrition …

Introduction The purpose of this study was to compare urate-lowering (UL) efficacy and
safety of daily febuxostat and allopurinol in subjects with gout and serum urate (sUA)≥ 8.0 …

Laser-induced graphene (LIG) suffers from serious decay in long-term biosensing, which
greatly restricts its practical applications. Herein, we report a new strategy to engineer the …

Objectives Despite the publication of hundreds of trials on gout and hyperuricemia,
management of these conditions remains suboptimal. We aimed to assess the quality and …

Hyperuricemia, the physiological prerequisite for gout, is linked to the presence and severity
of multiple comorbidities that affect longevity and well-being. By using the baseline data from …

This review article summarizes the relevant English literature on gout from 2010 through
April 2017. It emphasizes that the current epidemiology of gout indicates a rising prevalence …

There has been increased interest in gout in both academic and clinical practice settings.
Several reasons may explain this. The prevalence of both hyperuricemia and gout has risen …

Objective. To determine longterm urate-lowering efficacy and clinical benefits and safety of
therapy with febuxostat or allopurinol in subjects with gout. Methods. Subjects (n= 1086) in …